|
| |
| |
| |
|
| |
| |
CONVENTUS BIOMEDICAL SOLUTIONS, INC.
is a privately-held consulting firm specializing in development solutions and global regulatory strategies and submissions for investigational medicinal products in early development stages through Phase 3. The Conventus team includes full-time expert personnel, and expert affiliates with deep expertise in multiple technical disciplines, who together comprise an integrated team with successful experience in a broad range of therapeutic areas and vaccine indications. |
|
| |
|
|
| |
Click here to view recent projects |
|
| |
|
|
| |
KEY PERSONNEL |
| |
STEVEN A. KRADJIAN, RAC
President and Principal Regulatory Consultant |
| |
WILLIAM H. COVER, PhD, JD, RAC
VP of Technical Consulting & Business Development |
| |
ZENAIDA A. ORTEGA, MBA, CQE, CQA
Director of Quality Assurance |
| |
FRANCISCO X. ROSAS, MS, RAC
Senior Regulatory Associate |
| |
SERVICES OFFERED |
- Global Regulatory Submissions Management
- Pharmacology/Toxicology Planning and Oversight
- CMC Biologics and Small Molecules
- Quality Assurance/Project Management
- Regulatory Strategies for Biosimilars
- Regulatory Strategies for Combination Products
|
| |
|
| |
| |
|
|
|
| |
|
| |
| |
Conventus is derived from Latin convenire, meaning "to come together" which best describes our multiple consulting disciplines coming together in a single integrated development support model. Conventus also describes the relationship we like to build with our clients - coming together with a common objective.
|
| |
|
|
|
|
|
|
|
Copyright@2011 Conventus BioMedical Solutions, Inc.
|
|
| |
|
